tiprankstipranks
Regeneron Pharmaceuticals (REGN)
NASDAQ:REGN
US Market
Want to see REGN full AI Analyst Report?

Regeneron (REGN) Ownership - Who Owns Regeneron?

5,232 Followers

Regeneron (REGN) Ownership Overview

1.98%26.00%0.36%29.75%41.91%
0.36% Other Institutional Investors
29.75% ETFs
41.91% Public Companies and Individual Investors
The ownership structure of Regeneron (REGN) stock is a mix of institutional, retail, and individual investors. Approximately 56.11% of the company’s stock is owned by Institutional Investors, 1.98% is owned by Insiders, and 41.91% is owned by Public Companies and Individual Investors.
The ownership structure of Regeneron (REGN) stock is a mix of institutional, retail, and individual investors. Approximately 26.36% of the company’s stock is owned by Institutional Investors, 1.98% is owned by Insiders, and 29.75% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 10, 2025
xxxxxxxxxxxxx
$280766
Oct 31, 2025
xxxxxxxxxxxxx
$4252745

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$3444613008
Mar 31, 2024
xxxxxxxxxxxxx
$17557471
Mar 31, 2024
xxxxxxxxxxxxx
$3908786
Mar 31, 2024
xxxxxxxxxxxxx
$505307

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,120,762Institution7.88%5,383,090,715
6,945,247Institution6.74%4,603,865,331
5,395,226Institution5.24%3,576,387,411
4,458,238Institution4.33%2,955,276,805
4,133,500Institution4.01%2,740,014,480
4,100,922Institution3.98%2,718,419,175
3,411,656Institution3.31%2,261,518,529
1,971,733Institution1.91%1,307,022,371
1,930,169Institution1.87%1,279,470,427
1,775,365Institution1.72%1,176,853,951

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
6,945,247Institution6.74%4,603,865,331
3,411,656Institution3.31%2,261,518,529
1,775,365Institution1.72%1,176,853,951
1,142,625Institution1.11%757,423,260
931,886Institution0.90%617,728,592
806,416Institution0.78%534,557,038
760,233Institution0.74%503,943,251
634,610Institution0.62%420,670,277
618,380Institution0.60%409,911,734
602,903Institution0.59%399,652,341

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,307,126Institution3.21%2,033,154,922
2,639,279Institution2.56%1,622,575,944
2,171,021Institution2.11%1,439,126,400
1,372,727Institution1.33%909,953,274
1,208,373Institution1.17%817,138,074
1,207,883Institution1.17%905,235,836
969,267Institution0.94%595,885,966
748,650Institution0.73%506,259,590
722,434Institution0.70%478,887,050
714,475Institution0.69%483,149,429

FAQ

Who Owns Regeneron Pharmaceuticals (REGN)?
According to the latest TipRanks data, approximately 0.36% of the company's stock is held by institutional investors, 1.98% is held by insiders, and 41.91% is held by retail investors.
    What percentage of Regeneron Pharmaceuticals (REGN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.36% of Regeneron Pharmaceuticals (REGN) stock is held by institutional investors.
      What percentage of Regeneron Pharmaceuticals (REGN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 41.91% of Regeneron Pharmaceuticals (REGN) stock is held by retail investors.
        Who owns the most shares of Regeneron Pharmaceuticals (REGN)?
        Vanguard owns the most shares of Regeneron Pharmaceuticals (REGN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.